检测β?CTX和N?MID水平的双标记时间分辨免疫荧光分析方法的建立和评价

doi:10.13481/j.1671-587X.20210330

Abstract

Abstract: Objective

To develop a double-labeled time-resolved immunofluorescence analysis （TRFIA） method for the determination of the levels of β-cross-linked C-terminal telopeptide of type Ⅰ collagen（β-CTX） and N-terminal middle molecular fragment of osteocalein（N-MID） of osteocalcin，and to evaluate its detection performance.

Methods

The 4E5和2B7 monoclonal antibodies（MAb）of β-CTX and N-MID antigens were constructed， and then coated as coating antibodies in 96-well plates， and the antibodies were labeled with europium ion（Eu³⁺） and samarium ion（Sm³⁺），respectively. A double antibody sandwich TRFIA method was established and prepared into a kit. The detection performance was evaluated by the sensitivity， accuracy （dilution recovery）， specificity， precision， stability， and clinical sample alignment of the kit.

Results

The prepared double-labeled TRFIA Kit had a detection sensitivity of 0.025 μg·L^－1 for β-CTX and a linear range of 0.025－5.000 μg·L^－1；the detection sensitivity for N-MID was 0.5 μg·L^－1， and the linear range was 0.5－200.0 μg·L^－1； the average dilution recovery rate of β-CTX was 102.13%， and the average dilution recovery rate of N-MID was 103.02%；there were no obvious cross-reaction with other common bone test indicators and the specificity was high.The intra-assay coefficient of variation（CV） of β-CTX was 5.81%－7.82%， and the inter-assay CV was 5.97%－8.02%； the intra-assay CV of N-MID was 6.05%－8.32%， and the inter-assay CV was 6.14%－8.56%； the TRFIA Kit could be stored stably at 4 ℃ for half a year and stably stored at 37 ℃ for 7 d.

Conclusion

The established β-CTX and N-MID double-labeled TRFIA method has the advantages of high sensitivity， high specificity， high accuracy， convenience and speed， and is suitable for the detection of large-scale clinical samples.

Key words: β-cross-linked C-terminal telopeptide of type Ⅰ collagen, N-terminal middle molecular fragment of osteocalein, osteoporosis, double antibody sandwich, double-labeled time-resolved immunofluorescence analysis

CLC Number:

R331

Qian MAO, Cuicui CHEN, Huankun LIANG, Penge LIU, Shuhai ZHONG, Laiqing LI. Establishment and evaluation of a double?labeled time? resolved immunofluorescence analysis method for detecting levels of β?CTX and N?MID[J].Journal of Jilin University(Medicine Edition), 2021, 47(3): 770-776.

Figures/Tables 5

Fig. 1

Tab.1

Tab.2

Tab.3

Tab.4

References

1	马远征，王以朋，刘强，等. 中国老年骨质疏松诊疗指南（2018）［J］. 中国老年学杂志， 2019， 39（11）： 2557-2575.
2	XU Y C， WANG Q Y， HOU G， et al. A dual-label time-resolved fluorescence immunoassay for screening of osteoporosis based on simultaneous detection of C-terminal telopeptide（β-CTX） and aminoterminal propeptide （P1NP） of type Ⅰ procollagen［J］. Scand J Clin Lab Investig， 2019， 79（1/2）： 80-85.
3	游利. 骨质疏松症的现状、筛查和预防［J］. 中国全科医学， 2016， 19（14）： 1616-1619.
4	WANG J， YAN D， ZHAO A， et al. Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods［J］.Osteoporos Int，2019，30（7）：1491-1499.
5	CERQUEIRA M ， VILLARINO M R ， DANGOND C V， et al. AB0738Association between enthesopathic changes and bone turnover markers in patients with psoriatic arthritis［J］. Ann Rheumat Dis， 2016， 75：1157.
6	罗小玲，张群. 补肝益肾汤对肝肾阴虚型绝经后骨质疏松症患者血清性激素及BALP、β-CTX、N-MID水平的影响［J］. 四川中医， 2019， 37（3）： 162-164.
7	阙琦宏，万双林，马彦. 骨代谢指标在原发性骨质疏松症诊断中的价值探讨［J］. 全科医学临床与教育， 2015， 13（2）： 144-146.
8	安娜，纪丽慧，孟海燕，等. 2型糖尿病患者N-MID和β-CTX与骨密度的相关性研究［J］. 中国骨质疏松杂志， 2018， 24（12）： 1591-1595，1605.
9	辛甜甜，郭松林，王艺磊，等. 时间分辨荧光免疫分析的新进展［J］. 理化检验-化学分册， 2017， 53（1）： 112-118.
10	王泽洲，吴俊清，张永宁，等. 时间分辨荧光免疫分析技术的研究进展［J］. 四川畜牧兽医， 2015， 42（7）： 34-37.
11	LIU Z， HUANG J， OU R M， et al. A dual‐label time‐resolved fluorescence immunoassay for the simultaneous determination of ferritin and β2‐microglobulin［J］. J Clin Lab Anal， 2017，31（6）：e22132.
12	LIU Y， LIU Y H， BEI W J， et al. A dual-label time-resolved fluorescence immunoassay for the simultaneous determination of cystatin C and β₂-microglobulin in urine［J］. Br J Biomed Sci， 2017， 74（4）： 193-197.
13	叶燕，胡志刚，李梅，等. 丙型肝炎抗体Eu³⁺，Sm³⁺双标记分析法的建立及应用［J］. 中华核医学与分子影像杂志， 2018， 38（10）：677-680.
14	石文雅，童明宏，黄强，等. 时间分辨荧光分析技术在先天性甲状腺功能低下筛查中的应用［J］. 现代生物医学进展， 2015， 15（29）： 5658-5660.
15	戴薇，李世云，肖德俊，等. 时间分辨荧光免疫技术在梅毒特异性抗体筛查中的应用研究［J］. 国际检验医学杂志， 2015， 36（21）： 3117-3118.
16	张莹，吴景欢，洪平，等. 北京地区18~30岁成人骨密度影响因素分析［J］. 营养学报， 2016， 38（3）： 229-233.
17	林坚平. 骨生化标志物（NTX、CTX、OC、BSAP）和QCT骨密度测定在早期诊断兔实验性骨不连的作用［D］. 广州：南方医科大学， 2016.
18	张萌萌，张秀珍，邓伟民，等. 骨代谢生化指标临床应用专家共识（2020）［J］. 中国骨质疏松杂志， 2020， 26（6）： 781-796.
19	公爱凤. 骨代谢标志物25（OH）D3、β-CTX和Total-PⅠNP在老年骨质疏松症患者髋部脆性骨折诊断中的检测价值［J］. 临床和实验医学杂志， 2017， 16（6）： 555-558.
20	左晓佳,冯尽意,叶丽霖,等.新免疫标志组合在多参数流式细胞术检测多发性骨髓瘤微小残瘤病中的用[J].同济大学学报(医学版),2020,41(6):722-728.
21	黄宏兴，吴青，李跃华，等. 肌肉、骨骼与骨质疏松专家共识［J］. 中国骨质疏松杂志， 2016， 22（10）： 1221-1229.

Sample	Dilution	Concentration [ρ_B/(μg·L^－1)]	Determined [ρ_B/(μg·L^－1)]	Recovery rate (η/%)
β-CTX standard 1	1∶2	8.4	8.53	101.6
	1∶4	4.2	4.34	103.3
	1∶8	2.1	2.18	103.8
β-CTX standard 2	1∶2	9.6	9.47	98.6
	1∶4	4.8	4.92	102.6
	1∶8	2.4	2.51	104.6
β-CTX standard 3	1∶2	10.4	10.69	102.8
	1∶4	5.2	5.27	101.3
	1∶8	2.6	2.62	100.6
N-MID standard 1	1∶2	110.4	110.18	99.8
	1∶4	55.2	57.79	104.7
	1∶8	27.6	29.06	105.3
N-MID standard 2	1∶2	164.8	162.99	98.9
	1∶4	82.4	85.53	103.8
	1∶8	41.2	42.89	104.1
N-MID standard 3	1∶2	180.8	180.26	99.7
	1∶4	90.4	95.19	105.3
	1∶8	45.2	47.73	105.6

Item	Sample		Average [ρ_B/(μg·L^－1)]	Standard deviation	CV (η/%)
Item	Test	Concentration	Average [ρ_B/(μg·L^－1)]	Standard deviation	CV (η/%)
β-CTX	Intra-assay	Low	0.25	0.02	7.82
		Median	1.80	0.12	6.47
		High	3.70	0.21	5.81
	Inter-assay	Low	0.30	0.03	7.56
		Median	2.30	0.14	5.98
		High	3.90	0.26	6.75
N-MID	Intra-assay	Low	2.50	0.21	8.32
		Median	55.60	3.36	6.05
		High	113.40	8.41	7.42
	Inter-assay	Low	3.80	0.30	8.02
		Median	66.50	4.08	6.14
		High	124.30	9.48	7.63

Group	β-CTX（4 ℃）					N-MID（4 ℃）
	(month)0	1	2	3	6	(month)0		1	2	3	6
Sample 1	0.23	0.23	0.21	0.19	0.17	20.23		20.10	20.06	20.01	19.32
Sample 2	0.50	0.49	0.48	0.49	0.49	40.68		40.67	40.51	40.30	39.98
Sample 3	1.68	1.60	1.53	1.58	1.47	80.74		80.70	79.91	79.12	78.93
Sample 4	4.87	3.35	3.24	3.30	3.28	126.30		126.02	125.61	125.30	124.01
Sample 5	4.87	4.80	4.82	4.75	4.69	186.50		186.00	185.30	185.90	184.24
Group	β-CTX（37 ℃）						N-MID（37 ℃）
(t/d) 0		1	3	5	7	(t/d) 0		1	3	5	7
Sample 1	0.25	0.25	0.24	0.25	0.24	22.60		22.60	22.50	22.52	22.46
Sample 2	0.48	0.48	0.48	0.48	0.47	50.40		50.60	49.60	49.01	48.53
Sample 3	2.06	1.95	1.87	1.90	1.82	80.72		80.63	79.81	79.21	78.64
Sample 4	3.54	3.50	3.51	3.45	3.38	110.96		110.52	109.60	109.10	108.73
Sample 5	4.93	4.90	4.85	4.80	4.75	160.48		160.10	159.72	158.14	158.23

Group	β-CTX
	Osteoporotic patient				Non-osteoporotic patient
	Teens	Pregnant women	Postmenopausal women	Elderly	Teens	Pregnant women	Postmenopausal women	Elderly
CLIA
Positive	15	20	25	30	0	0	0	0
Negative	0	2	1	1	15	22	26	31
Coincidence rate (η/%)	100.00	90.00	96.00	96.67	100.00	100.00	100.00	100.00
ELISA
Positive	15	20	25	30	0	0	0	0
Negative	0	2	1	1	15	22	26	31
Coincidence rate (η/%)	100.00	90.00	96.00	96.67	100.00	100.00	100.00	100.00
TRFIA
Positive	15	20	25	30	0	0	0	0
Negative	0	2	1	1	15	22	26	31
Coincidence rate (η/%)	100.00	90.00	96.00	96.67	100.00	100.00	100.00	100.00
Group	N-MID
Group	Osteoporotic patient				Non-osteoporotic patient
	Teens	Pregnant women	Postmenopausal women	Elderly	Teens	Pregnant women	Postmenopausal women	Elderly
CLIA
Positive	14	22	24	31	0	0	0	0
Negative	1	0	2	0	15	22	26	31
Coincidence rate (η/%)	92.86	100.00	91.67	100.00	100.00	100.00	100.00	100.00
ELISA
Positive	14	22	24	31	0	0	0	0
Negative	1	0	2	0	15	22	26	31
Coincidence rate (η/%)	92.86	100.00	91.67	100.00	100.00	100.00	100.00	100.00
TRFIA
Positive	14	22	24	31	0	0	0	0
Negative	1	0	2	0	15	22	26	31
Coincidence rate (η/%)	92.86	100.00	91.67	100.00	100.00	100.00	100.00	100.00

[1]	Xueting CHI,Fangyuan CHEN,Zifeng PI,Guangfu LYU,Yuchen WANG,Yinqing LI,Xiaowei HUANG,Zhe LIN. Improvement effect of velvet antler polypeptide on postmenopausal osteoporosis in rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 963-969.
[2]	Xueting CHI,Xiaowei HUANG,Fangyuan CHEN,Gaofeng ZHOU,Jinji WANG,Guangfu LYU,Zhe LIN,Qing GONG. Improvement effect of velvet antler polypeptide in osteoporosis model rats and its effect on SIRT1/FOXO1 signaling pathway [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 120-127.
[3]	Yunfeng MA,Xiaofei HAN. Effects of salvianolate on osteoclast differentiation and bone resorption in osteoporotic rats by regulating SMAD2/FKBP1A/NF-κB axis [J]. Journal of Jilin University(Medicine Edition), 2022, 48(1): 111-121.
[4]	Xuanchen LIU,Xiaoying TIE,Yulin LIU, WangNing. Effect of polygonum multiflorum extract on osteoporosis and differentiation of bone marrow mesenchymal stem cells in agravic mice [J]. Journal of Jilin University(Medicine Edition), 2021, 47(6): 1386-1396.
[5]	Xining LI,Wei WENG,Zheyuan SHEN,Xiaojie DOU,Jikang MIN. Therapeutic effect of estradiol combined with 1,25-dihydroxyvitamin D3 on postmenopausal osteoporosis in rats [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 857-864.
[6]	Tianjiao MAO,Duo SUN,Xing GAO,Wei WEI,Xiheng LI,Kexin JIANG,Qiu JIANG,Jiang LI. [J]. Journal of Jilin University(Medicine Edition), 2021, 47(4): 896-903.
[7]	Kunying ZHU,Shijie GUO,Ruosen YUAN,Dong PAN,Chun ZHANG,Xiaoxu CHEN,Yanming YI,Yang YANG,Baisong ZHENG,Chunlai JIANG. Establishment and validation of double antibody sandwich ELISA for determination of varicella zoster virus glycoprotein level [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1315-1323.
[8]	SUN Jingchun, JIN Hui, YANG Wenqi, XU Hui. Effect of total flavonids of Rhizomadrynariae on sclerostin expression in bone tissue of osteoporosis rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(05): 911-916.
[9]	XU Dongliang, PENG Zhaohui, XIONG Meicai. Promotion effect of curcumin on implant osseointegration in osteoporosis rats [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 877-881.
[10]	LI Xining, CHEN Xiaochun, ZHU Yunfei, CAO Jingnan, ZOU Yiting, DU Xiao, WANG Qichun. Effect of PERK signaling pathway on osteoblast differentiation of female rats with experimental postmenopausal osteoporosis [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 260-264.
[11]	ZHU Tongtong, HUANG Liandi, LI Junwei, ZHAO Benzheng, JIANG Mengyang, LI Na, ZHAO Fan. Protective effect of icariin on osteoporosis in ovariectomized rats and its mechanism [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 915-919.
[12]	Temuribagen,Tubuxin,QIN Xiong,Hanbagenna,BAI Hai-hua. Preventive effect of Mongolian medicine Tonglaga -5 Pill on osteoporosis induced by retinoic acid in rats and its mechanism [J]. Journal of Jilin University Medicine Edition, 2014, 40(04): 763-767.
[13]	ZHANG Lei,ZHANG Shi-tao,ZENG Xian-yang,ZHANG Xiao-ping,HAO Fan-fan,WANG Feng,LI Wan-nan,FU Xue-qi. Cloning and expression of megakaryocyte protein tyrosine phosphatase 2　 and its relationship with osteoporosis  [J]. Journal of Jilin University Medicine Edition, 2013, 39(2): 227-231.
[14]	FU Jian-song, ZHUANG Xin-ming, FU Chang-feng, QU Zhi-ga,JIANG Yi-kun, LIU　Yi. Curative effect and security evaluation of ballon kyphoplasty in treatment for osteoporosis vertebral compression fractures [J]. J4, 2012, 38(5): 1003-1007.
[15]	ZHANG Xiao-bo, DENG Shi-lin . Association between habitual physical activity and onset of postmenopausal osteoporosis [J]. J4, 2012, 38(4): 775-778.

Establishment and evaluation of a double?labeled time? resolved immunofluorescence analysis method for detecting levels of β?CTX and N?MID

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References

Related Articles 15

Metrics

Comments

Recommended 10